Literature DB >> 23735142

Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder.

Masafumi Fukagawa1, Keitaro Yokoyama, Fumihiko Koiwa, Masatomo Taniguchi, Tetsuo Shoji, Junichiro James Kazama, Hirotaka Komaba, Ryoichi Ando, Takatoshi Kakuta, Hideki Fujii, Msasaaki Nakayama, Yugo Shibagaki, Seiji Fukumoto, Naohiko Fujii, Motoshi Hattori, Akira Ashida, Kunitoshi Iseki, Takashi Shigematsu, Yusuke Tsukamoto, Yoshiharu Tsubakihara, Tadashi Tomo, Hideki Hirakata, Tadao Akizawa.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23735142     DOI： 10.1111/1744-9987.12058

Source DB:  PubMed          Journal:  Ther Apher Dial        ISSN： 1744-9979            Impact factor:   1.762


× No keyword cloud information.
  123 in total

1.  Development of Severe Hyperparathyroidism Despite Short-Term Renal Replacement Therapy.

Authors:  Manabu Okada; Yoshihiro Tominaga; Takahisa Hiramitsu; Toshihiro Ichimori
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

2.  Associations between the levels of sclerostin, phosphate, and fibroblast growth factor-23 and treatment with vitamin D in hemodialysis patients with low intact PTH level.

Authors:  Y Asamiya; A Yajima; S Shimizu; S Otsubo; K Tsuchiya; K Nitta
Journal:  Osteoporos Int       Date:  2014-11-04       Impact factor: 4.507

3.  The Authors Reply.

Authors:  Hirotaka Komaba; Masatomo Taniguchi; Atsushi Wada; Kunitoshi Iseki; Yoshiharu Tsubakihara; Masafumi Fukagawa
Journal:  Kidney Int       Date:  2015-09       Impact factor: 10.612

4.  Not only for the risk of bone fracture.

Authors:  Masafumi Fukagawa
Journal:  J Bone Miner Metab       Date:  2015-05-12       Impact factor: 2.626

5.  Clinical value of calcium load test in differential diagnosis of different types of hyperparathyroidism.

Authors:  Xiaoxiao Zhu; Chang Shan; Qi Zhu; Lige Song; Yun Zhou; Jia Liu; Keqin Zhang
Journal:  Int J Clin Exp Med       Date:  2014-11-25

Review 6.  Mineral and bone disorders in kidney transplant recipients: reversible, irreversible, and de novo abnormalities.

Authors:  Takashi Hirukawa; Takatoshi Kakuta; Michio Nakamura; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2015-05-02       Impact factor: 2.801

7.  Perioperative hyperkalemia in hemodialysis patients undergoing parathyroidectomy for renal hyperparathyroidism.

Authors:  Guang Yang; Jing Wang; Jie Sun; Xiaoming Zha; Ningning Wang; Changying Xing
Journal:  Intern Emerg Med       Date:  2019-01-16       Impact factor: 3.397

8.  Changes in Markers of Mineral and Bone Disorders and Mortality in Incident Hemodialysis Patients.

Authors:  Melissa Soohoo; Mingliang Feng; Yoshitsugu Obi; Elani Streja; Connie M Rhee; Wei Ling Lau; Jialin Wang; Vanessa A Ravel; Steven Brunelli; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Am J Nephrol       Date:  2016-03-08       Impact factor: 3.754

9.  Thallium-201 washout rate of stress myocardial perfusion imaging as a predictor of mortality in diabetic kidney disease patients initiating hemodialysis: an observational, follow-up study.

Authors:  Toshihide Hayashi; Nobuhiko Joki; Yuri Tanaka; Masaki Iwasaki; Shun Kubo; Ai Matsukane; Yasunori Takahashi; Yoshihiko Imamura; Koichi Hirahata; Hiroki Hase
Journal:  Clin Exp Nephrol       Date:  2017-04-21       Impact factor: 2.801

Review 10.  Clinical features of CKD-MBD in Japan: cohort studies and registry.

Authors:  Takayuki Hamano; Yusuke Sakaguchi; Naohiko Fujii; Yoshitaka Isaka
Journal:  Clin Exp Nephrol       Date:  2016-12-09       Impact factor: 2.801
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.